-+ 0.00%
-+ 0.00%
-+ 0.00%

Cadrenal Therapeutics Reports Phase 2 CAD-1005 HIT Data and Schedules End-of-Phase 2 Meeting

Reuters·03/02/2026 13:11:27

Please log in to view news